AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

摘要

BACKGROUND AND PURPOSEWe have investigated how pre-incubating hCB2 CHO cells with the CB2 receptor antagonists/inverse agonists, AM630 and SR144528, affects how these and other ligands target hCB2 receptors in these cells or their membranes.